LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 87.86 | 770.25 | 11334 | 12543 | 0.9036 | 0.9503 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 87.86 | 770.25 | 13458 | 12543 | 1.0729 | 1.0353 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 3.21 | 770.25 | 878 | 904 | 0.9706 | 0.7584 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 3.21 | 770.25 | 853 | 904 | 0.9429 | 0.5525 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 5.44 | 770.25 | 947 | 1012 | 0.9351 | 0.6874 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 5.44 | 770.25 | 971 | 1012 | 0.9588 | 0.7978 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.66 | 770.25 | 1055 | 1090 | 0.9679 | 0.8739 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.66 | 770.25 | 1046 | 1090 | 0.9596 | 0.8421 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.06 | 770.25 | 1157 | 1218 | 0.9495 | 0.8494 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.06 | 770.25 | 1160 | 1218 | 0.9520 | 0.8567 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.28 | 770.25 | 1321 | 1358 | 0.9727 | 0.9334 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.28 | 770.25 | 1300 | 1358 | 0.9572 | 0.8959 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 14.50 | 770.25 | 1496 | 1497 | 0.9992 | 0.9983 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 14.50 | 770.25 | 1476 | 1497 | 0.9858 | 0.9704 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.73 | 770.25 | 1610 | 1664 | 0.9673 | 0.9410 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.73 | 770.25 | 1589 | 1664 | 0.9546 | 0.9182 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 18.95 | 770.25 | 1735 | 1832 | 0.9468 | 0.9144 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 18.95 | 770.25 | 1712 | 1832 | 0.9342 | 0.8941 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 21.17 | 770.25 | 1907 | 2008 | 0.9495 | 0.9265 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 21.17 | 770.25 | 1895 | 2008 | 0.9436 | 0.9177 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 23.39 | 770.25 | 2157 | 2244 | 0.9610 | 0.9491 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 23.39 | 770.25 | 2122 | 2244 | 0.9454 | 0.9286 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 25.62 | 770.25 | 2444 | 2514 | 0.9718 | 0.9668 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 25.62 | 770.25 | 2387 | 2514 | 0.9492 | 0.9398 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 27.84 | 770.25 | 2767 | 2833 | 0.9764 | 0.9748 | MN20160304_L02 | D17 |